Dr. Ho has over 20 years of biopharmaceutical industry experience. Prior to joining ReAlta, he held business development roles at a variety of biotechnology companies, including Nektar Therapeutics, BeiGene, Iovance, and Allergan. Dr. Ho has led negotiations to execute drug discovery collaborations and clinical development partnerships, as well as license agreements. Early in his career, he worked in early-stage drug company investments at D.E. Shaw, in finance as an equity research analyst covering major pharmaceutical companies, as well as in advertising and communications at Grey Healthcare Group. Dr. Ho has an MBA from the UCLA Anderson School of Management, a PhD in biology from the University of California, San Diego, and undergraduate degrees in chemistry and biology from the University of California, Irvine.
Back to Team